nodes	percent_of_prediction	percent_of_DWPC	metapath
Diflunisal—osteoarthritis—Prednisone—hematologic cancer	0.33	1	CpDpCtD
Diflunisal—ALB—hematologic cancer	0.101	1	CbGaD
Diflunisal—PTGS2—Lenalidomide—hematologic cancer	0.0592	0.177	CbGbCtD
Diflunisal—PTGS2—Thalidomide—hematologic cancer	0.0316	0.0946	CbGbCtD
Diflunisal—PTGS1—Bortezomib—hematologic cancer	0.0306	0.0917	CbGbCtD
Diflunisal—PTGS1—Thalidomide—hematologic cancer	0.0267	0.0799	CbGbCtD
Diflunisal—PTGS1—Ifosfamide—hematologic cancer	0.0235	0.0704	CbGbCtD
Diflunisal—PTGS1—Imatinib—hematologic cancer	0.0224	0.0672	CbGbCtD
Diflunisal—PTGS2—Triamcinolone—hematologic cancer	0.0219	0.0656	CbGbCtD
Diflunisal—PTGS2—Betamethasone—hematologic cancer	0.0188	0.0563	CbGbCtD
Diflunisal—ALB—Imatinib—hematologic cancer	0.0168	0.0502	CbGbCtD
Diflunisal—PTGS2—Cisplatin—hematologic cancer	0.0135	0.0405	CbGbCtD
Diflunisal—PTGS2—Etoposide—hematologic cancer	0.0133	0.0398	CbGbCtD
Diflunisal—PTGS1—Etoposide—hematologic cancer	0.0112	0.0336	CbGbCtD
Diflunisal—ALB—Prednisone—hematologic cancer	0.011	0.0331	CbGbCtD
Diflunisal—PTGS2—Dexamethasone—hematologic cancer	0.0109	0.0327	CbGbCtD
Diflunisal—ALB—Irinotecan—hematologic cancer	0.0105	0.0314	CbGbCtD
Diflunisal—SLC22A6—Methotrexate—hematologic cancer	0.0065	0.0195	CbGbCtD
Diflunisal—ALB—Methotrexate—hematologic cancer	0.00554	0.0166	CbGbCtD
Diflunisal—PTGS2—ovarian follicle—hematologic cancer	0.00368	0.312	CbGeAlD
Diflunisal—TTR—hematopoietic system—hematologic cancer	0.00128	0.108	CbGeAlD
Diflunisal—Niclosamide—STAT3—hematologic cancer	0.00119	0.296	CrCbGaD
Diflunisal—TTR—blood—hematologic cancer	0.000847	0.0719	CbGeAlD
Diflunisal—TTR—bone marrow—hematologic cancer	0.00082	0.0695	CbGeAlD
Diflunisal—TTR—lung—hematologic cancer	0.000743	0.063	CbGeAlD
Diflunisal—TTR—testis—hematologic cancer	0.000701	0.0594	CbGeAlD
Diflunisal—Olsalazine—IFNG—hematologic cancer	0.000605	0.15	CrCbGaD
Diflunisal—Olsalazine—ALOX5—hematologic cancer	0.000498	0.124	CrCbGaD
Diflunisal—Aminosalicylic Acid—ALOX5—hematologic cancer	0.000468	0.116	CrCbGaD
Diflunisal—PTGS1—hematopoietic system—hematologic cancer	0.000465	0.0395	CbGeAlD
Diflunisal—ALB—testis—hematologic cancer	0.000447	0.0379	CbGeAlD
Diflunisal—PTGS2—hematopoietic system—hematologic cancer	0.000445	0.0377	CbGeAlD
Diflunisal—Mesalazine—ALOX5—hematologic cancer	0.000367	0.0912	CrCbGaD
Diflunisal—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	0.000346	0.209	CbGdCrCtD
Diflunisal—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	0.000346	0.209	CbGdCrCtD
Diflunisal—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	0.000338	0.205	CbGdCrCtD
Diflunisal—ALB—lymph node—hematologic cancer	0.000324	0.0275	CbGeAlD
Diflunisal—PTGS1—blood—hematologic cancer	0.000308	0.0261	CbGeAlD
Diflunisal—Aminosalicylic Acid—MPO—hematologic cancer	0.000302	0.0749	CrCbGaD
Diflunisal—PTGS2—blood—hematologic cancer	0.000295	0.025	CbGeAlD
Diflunisal—PTGS2—bone marrow—hematologic cancer	0.000285	0.0242	CbGeAlD
Diflunisal—PTGS1—lung—hematologic cancer	0.00027	0.0229	CbGeAlD
Diflunisal—PTGS2—lung—hematologic cancer	0.000258	0.0219	CbGeAlD
Diflunisal—PTGS1—testis—hematologic cancer	0.000255	0.0216	CbGeAlD
Diflunisal—Mesalazine—MPO—hematologic cancer	0.000237	0.0588	CrCbGaD
Diflunisal—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.000209	0.126	CbGdCrCtD
Diflunisal—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	0.000209	0.126	CbGdCrCtD
Diflunisal—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.000204	0.124	CbGdCrCtD
Diflunisal—Flurbiprofen—UGT1A1—hematologic cancer	0.0002	0.0497	CrCbGaD
Diflunisal—PTGS1—lymph node—hematologic cancer	0.000185	0.0157	CbGeAlD
Diflunisal—PTGS2—lymph node—hematologic cancer	0.000177	0.015	CbGeAlD
Diflunisal—Salicylic acid—ALB—hematologic cancer	5.61e-05	0.0139	CrCbGaD
Diflunisal—Salicylic acid—ABCB1—hematologic cancer	5.35e-05	0.0133	CrCbGaD
Diflunisal—Flurbiprofen—ALB—hematologic cancer	4.91e-05	0.0122	CrCbGaD
Diflunisal—Urticaria—Etoposide—hematologic cancer	3.69e-05	0.000237	CcSEcCtD
Diflunisal—Jaundice—Doxorubicin—hematologic cancer	3.68e-05	0.000237	CcSEcCtD
Diflunisal—Stomatitis—Doxorubicin—hematologic cancer	3.68e-05	0.000237	CcSEcCtD
Diflunisal—Body temperature increased—Etoposide—hematologic cancer	3.67e-05	0.000236	CcSEcCtD
Diflunisal—Vertigo—Prednisone—hematologic cancer	3.66e-05	0.000235	CcSEcCtD
Diflunisal—Hepatitis—Epirubicin—hematologic cancer	3.66e-05	0.000235	CcSEcCtD
Diflunisal—Syncope—Prednisone—hematologic cancer	3.65e-05	0.000235	CcSEcCtD
Diflunisal—Tinnitus—Methotrexate—hematologic cancer	3.65e-05	0.000235	CcSEcCtD
Diflunisal—Vomiting—Vincristine—hematologic cancer	3.64e-05	0.000234	CcSEcCtD
Diflunisal—Anorexia—Betamethasone—hematologic cancer	3.64e-05	0.000234	CcSEcCtD
Diflunisal—Anorexia—Dexamethasone—hematologic cancer	3.64e-05	0.000234	CcSEcCtD
Diflunisal—Urticaria—Prednisolone—hematologic cancer	3.63e-05	0.000234	CcSEcCtD
Diflunisal—Asthenia—Cisplatin—hematologic cancer	3.63e-05	0.000234	CcSEcCtD
Diflunisal—Fatigue—Triamcinolone—hematologic cancer	3.63e-05	0.000233	CcSEcCtD
Diflunisal—Sweating—Doxorubicin—hematologic cancer	3.62e-05	0.000233	CcSEcCtD
Diflunisal—Rash—Vincristine—hematologic cancer	3.61e-05	0.000232	CcSEcCtD
Diflunisal—Dermatitis—Vincristine—hematologic cancer	3.61e-05	0.000232	CcSEcCtD
Diflunisal—Haematuria—Doxorubicin—hematologic cancer	3.6e-05	0.000231	CcSEcCtD
Diflunisal—Headache—Vincristine—hematologic cancer	3.59e-05	0.000231	CcSEcCtD
Diflunisal—Loss of consciousness—Prednisone—hematologic cancer	3.58e-05	0.00023	CcSEcCtD
Diflunisal—Nausea—Carmustine—hematologic cancer	3.56e-05	0.000229	CcSEcCtD
Diflunisal—Vomiting—Irinotecan—hematologic cancer	3.55e-05	0.000228	CcSEcCtD
Diflunisal—Vomiting—Mitoxantrone—hematologic cancer	3.55e-05	0.000228	CcSEcCtD
Diflunisal—Nausea—Alitretinoin—hematologic cancer	3.53e-05	0.000227	CcSEcCtD
Diflunisal—Visual impairment—Epirubicin—hematologic cancer	3.53e-05	0.000227	CcSEcCtD
Diflunisal—Agranulocytosis—Doxorubicin—hematologic cancer	3.52e-05	0.000226	CcSEcCtD
Diflunisal—Rash—Mitoxantrone—hematologic cancer	3.52e-05	0.000226	CcSEcCtD
Diflunisal—Rash—Irinotecan—hematologic cancer	3.52e-05	0.000226	CcSEcCtD
Diflunisal—Dermatitis—Mitoxantrone—hematologic cancer	3.51e-05	0.000226	CcSEcCtD
Diflunisal—Dermatitis—Irinotecan—hematologic cancer	3.51e-05	0.000226	CcSEcCtD
Diflunisal—Headache—Mitoxantrone—hematologic cancer	3.49e-05	0.000225	CcSEcCtD
Diflunisal—Headache—Irinotecan—hematologic cancer	3.49e-05	0.000225	CcSEcCtD
Diflunisal—Nausea—Ifosfamide—hematologic cancer	3.49e-05	0.000224	CcSEcCtD
Diflunisal—Feeling abnormal—Triamcinolone—hematologic cancer	3.47e-05	0.000223	CcSEcCtD
Diflunisal—Diarrhoea—Cisplatin—hematologic cancer	3.46e-05	0.000223	CcSEcCtD
Diflunisal—Erythema multiforme—Epirubicin—hematologic cancer	3.46e-05	0.000223	CcSEcCtD
Diflunisal—Vomiting—Gemcitabine—hematologic cancer	3.45e-05	0.000222	CcSEcCtD
Diflunisal—Insomnia—Betamethasone—hematologic cancer	3.45e-05	0.000222	CcSEcCtD
Diflunisal—Insomnia—Dexamethasone—hematologic cancer	3.45e-05	0.000222	CcSEcCtD
Diflunisal—Paraesthesia—Betamethasone—hematologic cancer	3.43e-05	0.000221	CcSEcCtD
Diflunisal—Paraesthesia—Dexamethasone—hematologic cancer	3.43e-05	0.000221	CcSEcCtD
Diflunisal—Rash—Gemcitabine—hematologic cancer	3.43e-05	0.00022	CcSEcCtD
Diflunisal—Dermatitis—Gemcitabine—hematologic cancer	3.42e-05	0.00022	CcSEcCtD
Diflunisal—Hypersensitivity—Etoposide—hematologic cancer	3.42e-05	0.00022	CcSEcCtD
Diflunisal—Tinnitus—Epirubicin—hematologic cancer	3.41e-05	0.00022	CcSEcCtD
Diflunisal—Headache—Gemcitabine—hematologic cancer	3.4e-05	0.000219	CcSEcCtD
Diflunisal—Nausea—Vincristine—hematologic cancer	3.4e-05	0.000219	CcSEcCtD
Diflunisal—Flushing—Epirubicin—hematologic cancer	3.4e-05	0.000219	CcSEcCtD
Diflunisal—Hepatitis—Doxorubicin—hematologic cancer	3.39e-05	0.000218	CcSEcCtD
Diflunisal—Hypersensitivity—Prednisolone—hematologic cancer	3.37e-05	0.000217	CcSEcCtD
Diflunisal—Dyspepsia—Dexamethasone—hematologic cancer	3.36e-05	0.000216	CcSEcCtD
Diflunisal—Dyspepsia—Betamethasone—hematologic cancer	3.36e-05	0.000216	CcSEcCtD
Diflunisal—Urticaria—Triamcinolone—hematologic cancer	3.34e-05	0.000215	CcSEcCtD
Diflunisal—Asthenia—Etoposide—hematologic cancer	3.33e-05	0.000214	CcSEcCtD
Diflunisal—Body temperature increased—Triamcinolone—hematologic cancer	3.33e-05	0.000214	CcSEcCtD
Diflunisal—Oedema—Prednisone—hematologic cancer	3.32e-05	0.000214	CcSEcCtD
Diflunisal—Anaphylactic shock—Prednisone—hematologic cancer	3.32e-05	0.000214	CcSEcCtD
Diflunisal—Decreased appetite—Dexamethasone—hematologic cancer	3.32e-05	0.000213	CcSEcCtD
Diflunisal—Decreased appetite—Betamethasone—hematologic cancer	3.32e-05	0.000213	CcSEcCtD
Diflunisal—Nausea—Mitoxantrone—hematologic cancer	3.31e-05	0.000213	CcSEcCtD
Diflunisal—Nausea—Irinotecan—hematologic cancer	3.31e-05	0.000213	CcSEcCtD
Diflunisal—Fatigue—Betamethasone—hematologic cancer	3.29e-05	0.000212	CcSEcCtD
Diflunisal—Fatigue—Dexamethasone—hematologic cancer	3.29e-05	0.000212	CcSEcCtD
Diflunisal—Pruritus—Etoposide—hematologic cancer	3.28e-05	0.000211	CcSEcCtD
Diflunisal—Shock—Prednisone—hematologic cancer	3.27e-05	0.00021	CcSEcCtD
Diflunisal—Visual impairment—Doxorubicin—hematologic cancer	3.26e-05	0.00021	CcSEcCtD
Diflunisal—Nausea—Gemcitabine—hematologic cancer	3.23e-05	0.000208	CcSEcCtD
Diflunisal—Vomiting—Cisplatin—hematologic cancer	3.22e-05	0.000207	CcSEcCtD
Diflunisal—Hyperhidrosis—Prednisone—hematologic cancer	3.21e-05	0.000207	CcSEcCtD
Diflunisal—Vision blurred—Methotrexate—hematologic cancer	3.21e-05	0.000206	CcSEcCtD
Diflunisal—Erythema multiforme—Doxorubicin—hematologic cancer	3.2e-05	0.000206	CcSEcCtD
Diflunisal—Rash—Cisplatin—hematologic cancer	3.19e-05	0.000205	CcSEcCtD
Diflunisal—Dermatitis—Cisplatin—hematologic cancer	3.19e-05	0.000205	CcSEcCtD
Diflunisal—Diarrhoea—Etoposide—hematologic cancer	3.17e-05	0.000204	CcSEcCtD
Diflunisal—Anorexia—Prednisone—hematologic cancer	3.17e-05	0.000204	CcSEcCtD
Diflunisal—Tinnitus—Doxorubicin—hematologic cancer	3.16e-05	0.000203	CcSEcCtD
Diflunisal—Feeling abnormal—Dexamethasone—hematologic cancer	3.15e-05	0.000202	CcSEcCtD
Diflunisal—Feeling abnormal—Betamethasone—hematologic cancer	3.15e-05	0.000202	CcSEcCtD
Diflunisal—Flushing—Doxorubicin—hematologic cancer	3.14e-05	0.000202	CcSEcCtD
Diflunisal—Flatulence—Epirubicin—hematologic cancer	3.14e-05	0.000202	CcSEcCtD
Diflunisal—Tension—Epirubicin—hematologic cancer	3.13e-05	0.000201	CcSEcCtD
Diflunisal—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.12e-05	0.000201	CcSEcCtD
Diflunisal—Gastrointestinal pain—Betamethasone—hematologic cancer	3.12e-05	0.000201	CcSEcCtD
Diflunisal—Hypersensitivity—Triamcinolone—hematologic cancer	3.1e-05	0.000199	CcSEcCtD
Diflunisal—Nervousness—Epirubicin—hematologic cancer	3.09e-05	0.000199	CcSEcCtD
Diflunisal—Dizziness—Etoposide—hematologic cancer	3.07e-05	0.000197	CcSEcCtD
Diflunisal—Muscle spasms—Epirubicin—hematologic cancer	3.06e-05	0.000197	CcSEcCtD
Diflunisal—Vertigo—Methotrexate—hematologic cancer	3.06e-05	0.000197	CcSEcCtD
Diflunisal—Urticaria—Dexamethasone—hematologic cancer	3.03e-05	0.000195	CcSEcCtD
Diflunisal—Urticaria—Betamethasone—hematologic cancer	3.03e-05	0.000195	CcSEcCtD
Diflunisal—Dizziness—Prednisolone—hematologic cancer	3.03e-05	0.000195	CcSEcCtD
Diflunisal—Asthenia—Triamcinolone—hematologic cancer	3.02e-05	0.000194	CcSEcCtD
Diflunisal—Body temperature increased—Dexamethasone—hematologic cancer	3.02e-05	0.000194	CcSEcCtD
Diflunisal—Body temperature increased—Betamethasone—hematologic cancer	3.02e-05	0.000194	CcSEcCtD
Diflunisal—Nausea—Cisplatin—hematologic cancer	3.01e-05	0.000193	CcSEcCtD
Diflunisal—Insomnia—Prednisone—hematologic cancer	3.01e-05	0.000193	CcSEcCtD
Diflunisal—Vision blurred—Epirubicin—hematologic cancer	3e-05	0.000193	CcSEcCtD
Diflunisal—Paraesthesia—Prednisone—hematologic cancer	2.99e-05	0.000192	CcSEcCtD
Diflunisal—Pruritus—Triamcinolone—hematologic cancer	2.98e-05	0.000192	CcSEcCtD
Diflunisal—Vomiting—Etoposide—hematologic cancer	2.95e-05	0.00019	CcSEcCtD
Diflunisal—Dyspepsia—Prednisone—hematologic cancer	2.93e-05	0.000188	CcSEcCtD
Diflunisal—Rash—Etoposide—hematologic cancer	2.92e-05	0.000188	CcSEcCtD
Diflunisal—Dermatitis—Etoposide—hematologic cancer	2.92e-05	0.000188	CcSEcCtD
Diflunisal—Headache—Etoposide—hematologic cancer	2.91e-05	0.000187	CcSEcCtD
Diflunisal—Flatulence—Doxorubicin—hematologic cancer	2.9e-05	0.000187	CcSEcCtD
Diflunisal—Chest pain—Methotrexate—hematologic cancer	2.9e-05	0.000186	CcSEcCtD
Diflunisal—Tension—Doxorubicin—hematologic cancer	2.89e-05	0.000186	CcSEcCtD
Diflunisal—Decreased appetite—Prednisone—hematologic cancer	2.89e-05	0.000186	CcSEcCtD
Diflunisal—Rash—Prednisolone—hematologic cancer	2.88e-05	0.000186	CcSEcCtD
Diflunisal—Dermatitis—Prednisolone—hematologic cancer	2.88e-05	0.000185	CcSEcCtD
Diflunisal—Fatigue—Prednisone—hematologic cancer	2.87e-05	0.000184	CcSEcCtD
Diflunisal—Headache—Prednisolone—hematologic cancer	2.87e-05	0.000184	CcSEcCtD
Diflunisal—Nervousness—Doxorubicin—hematologic cancer	2.86e-05	0.000184	CcSEcCtD
Diflunisal—Vertigo—Epirubicin—hematologic cancer	2.86e-05	0.000184	CcSEcCtD
Diflunisal—Syncope—Epirubicin—hematologic cancer	2.86e-05	0.000184	CcSEcCtD
Diflunisal—Constipation—Prednisone—hematologic cancer	2.84e-05	0.000183	CcSEcCtD
Diflunisal—Muscle spasms—Doxorubicin—hematologic cancer	2.83e-05	0.000182	CcSEcCtD
Diflunisal—Palpitations—Epirubicin—hematologic cancer	2.82e-05	0.000181	CcSEcCtD
Diflunisal—Confusional state—Methotrexate—hematologic cancer	2.8e-05	0.00018	CcSEcCtD
Diflunisal—Loss of consciousness—Epirubicin—hematologic cancer	2.8e-05	0.00018	CcSEcCtD
Diflunisal—Dizziness—Triamcinolone—hematologic cancer	2.78e-05	0.000179	CcSEcCtD
Diflunisal—Anaphylactic shock—Methotrexate—hematologic cancer	2.78e-05	0.000179	CcSEcCtD
Diflunisal—Vision blurred—Doxorubicin—hematologic cancer	2.78e-05	0.000179	CcSEcCtD
Diflunisal—Nausea—Etoposide—hematologic cancer	2.76e-05	0.000177	CcSEcCtD
Diflunisal—Feeling abnormal—Prednisone—hematologic cancer	2.74e-05	0.000176	CcSEcCtD
Diflunisal—Asthenia—Dexamethasone—hematologic cancer	2.74e-05	0.000176	CcSEcCtD
Diflunisal—Asthenia—Betamethasone—hematologic cancer	2.74e-05	0.000176	CcSEcCtD
Diflunisal—Thrombocytopenia—Methotrexate—hematologic cancer	2.72e-05	0.000175	CcSEcCtD
Diflunisal—Gastrointestinal pain—Prednisone—hematologic cancer	2.72e-05	0.000175	CcSEcCtD
Diflunisal—Nausea—Prednisolone—hematologic cancer	2.72e-05	0.000175	CcSEcCtD
Diflunisal—Chest pain—Epirubicin—hematologic cancer	2.71e-05	0.000174	CcSEcCtD
Diflunisal—Pruritus—Dexamethasone—hematologic cancer	2.7e-05	0.000174	CcSEcCtD
Diflunisal—Pruritus—Betamethasone—hematologic cancer	2.7e-05	0.000174	CcSEcCtD
Diflunisal—Hyperhidrosis—Methotrexate—hematologic cancer	2.69e-05	0.000173	CcSEcCtD
Diflunisal—Vomiting—Triamcinolone—hematologic cancer	2.68e-05	0.000172	CcSEcCtD
Diflunisal—Rash—Triamcinolone—hematologic cancer	2.65e-05	0.000171	CcSEcCtD
Diflunisal—Dermatitis—Triamcinolone—hematologic cancer	2.65e-05	0.000171	CcSEcCtD
Diflunisal—Vertigo—Doxorubicin—hematologic cancer	2.65e-05	0.00017	CcSEcCtD
Diflunisal—Anorexia—Methotrexate—hematologic cancer	2.65e-05	0.00017	CcSEcCtD
Diflunisal—Syncope—Doxorubicin—hematologic cancer	2.64e-05	0.00017	CcSEcCtD
Diflunisal—Urticaria—Prednisone—hematologic cancer	2.64e-05	0.00017	CcSEcCtD
Diflunisal—Headache—Triamcinolone—hematologic cancer	2.64e-05	0.00017	CcSEcCtD
Diflunisal—Body temperature increased—Prednisone—hematologic cancer	2.63e-05	0.000169	CcSEcCtD
Diflunisal—Confusional state—Epirubicin—hematologic cancer	2.62e-05	0.000169	CcSEcCtD
Diflunisal—Diarrhoea—Dexamethasone—hematologic cancer	2.61e-05	0.000168	CcSEcCtD
Diflunisal—Diarrhoea—Betamethasone—hematologic cancer	2.61e-05	0.000168	CcSEcCtD
Diflunisal—Palpitations—Doxorubicin—hematologic cancer	2.61e-05	0.000168	CcSEcCtD
Diflunisal—Oedema—Epirubicin—hematologic cancer	2.6e-05	0.000167	CcSEcCtD
Diflunisal—Anaphylactic shock—Epirubicin—hematologic cancer	2.6e-05	0.000167	CcSEcCtD
Diflunisal—Loss of consciousness—Doxorubicin—hematologic cancer	2.59e-05	0.000167	CcSEcCtD
Diflunisal—Shock—Epirubicin—hematologic cancer	2.56e-05	0.000165	CcSEcCtD
Diflunisal—Thrombocytopenia—Epirubicin—hematologic cancer	2.55e-05	0.000164	CcSEcCtD
Diflunisal—Dizziness—Betamethasone—hematologic cancer	2.52e-05	0.000162	CcSEcCtD
Diflunisal—Dizziness—Dexamethasone—hematologic cancer	2.52e-05	0.000162	CcSEcCtD
Diflunisal—Hyperhidrosis—Epirubicin—hematologic cancer	2.51e-05	0.000162	CcSEcCtD
Diflunisal—Insomnia—Methotrexate—hematologic cancer	2.51e-05	0.000162	CcSEcCtD
Diflunisal—Chest pain—Doxorubicin—hematologic cancer	2.51e-05	0.000161	CcSEcCtD
Diflunisal—Nausea—Triamcinolone—hematologic cancer	2.5e-05	0.000161	CcSEcCtD
Diflunisal—Paraesthesia—Methotrexate—hematologic cancer	2.5e-05	0.000161	CcSEcCtD
Diflunisal—Anorexia—Epirubicin—hematologic cancer	2.48e-05	0.000159	CcSEcCtD
Diflunisal—Dyspnoea—Methotrexate—hematologic cancer	2.48e-05	0.000159	CcSEcCtD
Diflunisal—Somnolence—Methotrexate—hematologic cancer	2.47e-05	0.000159	CcSEcCtD
Diflunisal—Hypersensitivity—Prednisone—hematologic cancer	2.45e-05	0.000158	CcSEcCtD
Diflunisal—Dyspepsia—Methotrexate—hematologic cancer	2.45e-05	0.000157	CcSEcCtD
Diflunisal—Vomiting—Betamethasone—hematologic cancer	2.43e-05	0.000156	CcSEcCtD
Diflunisal—Vomiting—Dexamethasone—hematologic cancer	2.43e-05	0.000156	CcSEcCtD
Diflunisal—Confusional state—Doxorubicin—hematologic cancer	2.43e-05	0.000156	CcSEcCtD
Diflunisal—Decreased appetite—Methotrexate—hematologic cancer	2.42e-05	0.000155	CcSEcCtD
Diflunisal—Rash—Betamethasone—hematologic cancer	2.41e-05	0.000155	CcSEcCtD
Diflunisal—Rash—Dexamethasone—hematologic cancer	2.41e-05	0.000155	CcSEcCtD
Diflunisal—Oedema—Doxorubicin—hematologic cancer	2.41e-05	0.000155	CcSEcCtD
Diflunisal—Anaphylactic shock—Doxorubicin—hematologic cancer	2.41e-05	0.000155	CcSEcCtD
Diflunisal—Dermatitis—Betamethasone—hematologic cancer	2.4e-05	0.000155	CcSEcCtD
Diflunisal—Dermatitis—Dexamethasone—hematologic cancer	2.4e-05	0.000155	CcSEcCtD
Diflunisal—Fatigue—Methotrexate—hematologic cancer	2.4e-05	0.000154	CcSEcCtD
Diflunisal—Headache—Dexamethasone—hematologic cancer	2.39e-05	0.000154	CcSEcCtD
Diflunisal—Headache—Betamethasone—hematologic cancer	2.39e-05	0.000154	CcSEcCtD
Diflunisal—Asthenia—Prednisone—hematologic cancer	2.39e-05	0.000153	CcSEcCtD
Diflunisal—Shock—Doxorubicin—hematologic cancer	2.37e-05	0.000152	CcSEcCtD
Diflunisal—Thrombocytopenia—Doxorubicin—hematologic cancer	2.36e-05	0.000152	CcSEcCtD
Diflunisal—Pruritus—Prednisone—hematologic cancer	2.35e-05	0.000151	CcSEcCtD
Diflunisal—Insomnia—Epirubicin—hematologic cancer	2.35e-05	0.000151	CcSEcCtD
Diflunisal—Paraesthesia—Epirubicin—hematologic cancer	2.33e-05	0.00015	CcSEcCtD
Diflunisal—Hyperhidrosis—Doxorubicin—hematologic cancer	2.33e-05	0.00015	CcSEcCtD
Diflunisal—Dyspnoea—Epirubicin—hematologic cancer	2.32e-05	0.000149	CcSEcCtD
Diflunisal—Somnolence—Epirubicin—hematologic cancer	2.31e-05	0.000149	CcSEcCtD
Diflunisal—Anorexia—Doxorubicin—hematologic cancer	2.29e-05	0.000148	CcSEcCtD
Diflunisal—Feeling abnormal—Methotrexate—hematologic cancer	2.29e-05	0.000147	CcSEcCtD
Diflunisal—Dyspepsia—Epirubicin—hematologic cancer	2.29e-05	0.000147	CcSEcCtD
Diflunisal—Diarrhoea—Prednisone—hematologic cancer	2.27e-05	0.000146	CcSEcCtD
Diflunisal—Gastrointestinal pain—Methotrexate—hematologic cancer	2.27e-05	0.000146	CcSEcCtD
Diflunisal—Nausea—Dexamethasone—hematologic cancer	2.27e-05	0.000146	CcSEcCtD
Diflunisal—Nausea—Betamethasone—hematologic cancer	2.27e-05	0.000146	CcSEcCtD
Diflunisal—Decreased appetite—Epirubicin—hematologic cancer	2.26e-05	0.000145	CcSEcCtD
Diflunisal—Fatigue—Epirubicin—hematologic cancer	2.24e-05	0.000144	CcSEcCtD
Diflunisal—Constipation—Epirubicin—hematologic cancer	2.22e-05	0.000143	CcSEcCtD
Diflunisal—Urticaria—Methotrexate—hematologic cancer	2.21e-05	0.000142	CcSEcCtD
Diflunisal—Dizziness—Prednisone—hematologic cancer	2.2e-05	0.000141	CcSEcCtD
Diflunisal—Body temperature increased—Methotrexate—hematologic cancer	2.2e-05	0.000141	CcSEcCtD
Diflunisal—Insomnia—Doxorubicin—hematologic cancer	2.18e-05	0.00014	CcSEcCtD
Diflunisal—Paraesthesia—Doxorubicin—hematologic cancer	2.16e-05	0.000139	CcSEcCtD
Diflunisal—Dyspnoea—Doxorubicin—hematologic cancer	2.15e-05	0.000138	CcSEcCtD
Diflunisal—Feeling abnormal—Epirubicin—hematologic cancer	2.14e-05	0.000138	CcSEcCtD
Diflunisal—Somnolence—Doxorubicin—hematologic cancer	2.14e-05	0.000138	CcSEcCtD
Diflunisal—Gastrointestinal pain—Epirubicin—hematologic cancer	2.13e-05	0.000137	CcSEcCtD
Diflunisal—Dyspepsia—Doxorubicin—hematologic cancer	2.12e-05	0.000136	CcSEcCtD
Diflunisal—Vomiting—Prednisone—hematologic cancer	2.11e-05	0.000136	CcSEcCtD
Diflunisal—Rash—Prednisone—hematologic cancer	2.1e-05	0.000135	CcSEcCtD
Diflunisal—Dermatitis—Prednisone—hematologic cancer	2.09e-05	0.000135	CcSEcCtD
Diflunisal—Decreased appetite—Doxorubicin—hematologic cancer	2.09e-05	0.000135	CcSEcCtD
Diflunisal—Headache—Prednisone—hematologic cancer	2.08e-05	0.000134	CcSEcCtD
Diflunisal—Fatigue—Doxorubicin—hematologic cancer	2.07e-05	0.000133	CcSEcCtD
Diflunisal—Urticaria—Epirubicin—hematologic cancer	2.07e-05	0.000133	CcSEcCtD
Diflunisal—Constipation—Doxorubicin—hematologic cancer	2.06e-05	0.000132	CcSEcCtD
Diflunisal—Body temperature increased—Epirubicin—hematologic cancer	2.06e-05	0.000132	CcSEcCtD
Diflunisal—Hypersensitivity—Methotrexate—hematologic cancer	2.05e-05	0.000132	CcSEcCtD
Diflunisal—Asthenia—Methotrexate—hematologic cancer	1.99e-05	0.000128	CcSEcCtD
Diflunisal—Feeling abnormal—Doxorubicin—hematologic cancer	1.98e-05	0.000128	CcSEcCtD
Diflunisal—Nausea—Prednisone—hematologic cancer	1.97e-05	0.000127	CcSEcCtD
Diflunisal—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.97e-05	0.000127	CcSEcCtD
Diflunisal—Pruritus—Methotrexate—hematologic cancer	1.97e-05	0.000126	CcSEcCtD
Diflunisal—Hypersensitivity—Epirubicin—hematologic cancer	1.92e-05	0.000123	CcSEcCtD
Diflunisal—Urticaria—Doxorubicin—hematologic cancer	1.91e-05	0.000123	CcSEcCtD
Diflunisal—Body temperature increased—Doxorubicin—hematologic cancer	1.9e-05	0.000122	CcSEcCtD
Diflunisal—Diarrhoea—Methotrexate—hematologic cancer	1.9e-05	0.000122	CcSEcCtD
Diflunisal—Asthenia—Epirubicin—hematologic cancer	1.87e-05	0.00012	CcSEcCtD
Diflunisal—Pruritus—Epirubicin—hematologic cancer	1.84e-05	0.000118	CcSEcCtD
Diflunisal—Dizziness—Methotrexate—hematologic cancer	1.84e-05	0.000118	CcSEcCtD
Diflunisal—Diarrhoea—Epirubicin—hematologic cancer	1.78e-05	0.000114	CcSEcCtD
Diflunisal—Hypersensitivity—Doxorubicin—hematologic cancer	1.77e-05	0.000114	CcSEcCtD
Diflunisal—Vomiting—Methotrexate—hematologic cancer	1.77e-05	0.000114	CcSEcCtD
Diflunisal—Rash—Methotrexate—hematologic cancer	1.75e-05	0.000113	CcSEcCtD
Diflunisal—Dermatitis—Methotrexate—hematologic cancer	1.75e-05	0.000113	CcSEcCtD
Diflunisal—Headache—Methotrexate—hematologic cancer	1.74e-05	0.000112	CcSEcCtD
Diflunisal—Asthenia—Doxorubicin—hematologic cancer	1.73e-05	0.000111	CcSEcCtD
Diflunisal—Dizziness—Epirubicin—hematologic cancer	1.72e-05	0.000111	CcSEcCtD
Diflunisal—Pruritus—Doxorubicin—hematologic cancer	1.7e-05	0.00011	CcSEcCtD
Diflunisal—Vomiting—Epirubicin—hematologic cancer	1.65e-05	0.000106	CcSEcCtD
Diflunisal—Nausea—Methotrexate—hematologic cancer	1.65e-05	0.000106	CcSEcCtD
Diflunisal—Diarrhoea—Doxorubicin—hematologic cancer	1.65e-05	0.000106	CcSEcCtD
Diflunisal—Rash—Epirubicin—hematologic cancer	1.64e-05	0.000105	CcSEcCtD
Diflunisal—Dermatitis—Epirubicin—hematologic cancer	1.64e-05	0.000105	CcSEcCtD
Diflunisal—Headache—Epirubicin—hematologic cancer	1.63e-05	0.000105	CcSEcCtD
Diflunisal—Dizziness—Doxorubicin—hematologic cancer	1.59e-05	0.000102	CcSEcCtD
Diflunisal—Nausea—Epirubicin—hematologic cancer	1.54e-05	9.94e-05	CcSEcCtD
Diflunisal—Vomiting—Doxorubicin—hematologic cancer	1.53e-05	9.84e-05	CcSEcCtD
Diflunisal—Rash—Doxorubicin—hematologic cancer	1.52e-05	9.76e-05	CcSEcCtD
Diflunisal—Dermatitis—Doxorubicin—hematologic cancer	1.52e-05	9.75e-05	CcSEcCtD
Diflunisal—Headache—Doxorubicin—hematologic cancer	1.51e-05	9.7e-05	CcSEcCtD
Diflunisal—Nausea—Doxorubicin—hematologic cancer	1.43e-05	9.19e-05	CcSEcCtD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	8.33e-06	0.000133	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ARNTL—hematologic cancer	8.3e-06	0.000133	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ALOX5—hematologic cancer	8.27e-06	0.000132	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	8.27e-06	0.000132	CbGpPWpGaD
Diflunisal—TTR—Disease—STAT3—hematologic cancer	8.19e-06	0.000131	CbGpPWpGaD
Diflunisal—TTR—Disease—NRAS—hematologic cancer	8.17e-06	0.000131	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—ABCB1—hematologic cancer	8.16e-06	0.000131	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—FGF2—hematologic cancer	8.15e-06	0.00013	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IL2RA—hematologic cancer	8.15e-06	0.00013	CbGpPWpGaD
Diflunisal—PTGS2—Disease—LCK—hematologic cancer	8.13e-06	0.00013	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—SRC—hematologic cancer	8.09e-06	0.000129	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CA9—hematologic cancer	8.08e-06	0.000129	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ACP5—hematologic cancer	8.08e-06	0.000129	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PIK3R1—hematologic cancer	8.04e-06	0.000129	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—NUP98—hematologic cancer	8.01e-06	0.000128	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.99e-06	0.000128	CbGpPWpGaD
Diflunisal—PTGS2—Disease—H3F3A—hematologic cancer	7.97e-06	0.000128	CbGpPWpGaD
Diflunisal—ALB—Metabolism—NCOR2—hematologic cancer	7.97e-06	0.000128	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—VEGFA—hematologic cancer	7.88e-06	0.000126	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PDGFB—hematologic cancer	7.87e-06	0.000126	CbGpPWpGaD
Diflunisal—TTR—Disease—MAPK3—hematologic cancer	7.83e-06	0.000125	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—JAK2—hematologic cancer	7.82e-06	0.000125	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ADCY7—hematologic cancer	7.78e-06	0.000124	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—NCOA3—hematologic cancer	7.78e-06	0.000124	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PRKCZ—hematologic cancer	7.75e-06	0.000124	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—NUP214—hematologic cancer	7.72e-06	0.000124	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.64e-06	0.000122	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—CDK2—hematologic cancer	7.63e-06	0.000122	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MDM2—hematologic cancer	7.63e-06	0.000122	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CALR—hematologic cancer	7.61e-06	0.000122	CbGpPWpGaD
Diflunisal—TTR—Disease—MYC—hematologic cancer	7.61e-06	0.000122	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PIK3CA—hematologic cancer	7.59e-06	0.000122	CbGpPWpGaD
Diflunisal—ALB—Metabolism—IDH1—hematologic cancer	7.59e-06	0.000122	CbGpPWpGaD
Diflunisal—TTR—Disease—TGFB1—hematologic cancer	7.59e-06	0.000121	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ABCG2—hematologic cancer	7.57e-06	0.000121	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—MTR—hematologic cancer	7.57e-06	0.000121	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CD44—hematologic cancer	7.53e-06	0.000121	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—NQO1—hematologic cancer	7.53e-06	0.000121	CbGpPWpGaD
Diflunisal—ALB—Metabolism—TXN—hematologic cancer	7.51e-06	0.00012	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTO1—hematologic cancer	7.51e-06	0.00012	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ABCC3—hematologic cancer	7.51e-06	0.00012	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PARP1—hematologic cancer	7.49e-06	0.00012	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	7.45e-06	0.000119	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MTOR—hematologic cancer	7.42e-06	0.000119	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PIK3CB—hematologic cancer	7.42e-06	0.000119	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ENO2—hematologic cancer	7.42e-06	0.000119	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	7.38e-06	0.000118	CbGpPWpGaD
Diflunisal—PTGS2—Disease—FBXW7—hematologic cancer	7.36e-06	0.000118	CbGpPWpGaD
Diflunisal—ALB—Metabolism—SPHK1—hematologic cancer	7.35e-06	0.000118	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—MAPK14—hematologic cancer	7.32e-06	0.000117	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	7.23e-06	0.000116	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HDAC2—hematologic cancer	7.22e-06	0.000116	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CXCR4—hematologic cancer	7.22e-06	0.000116	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GSTT1—hematologic cancer	7.2e-06	0.000115	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CD44—hematologic cancer	7.14e-06	0.000114	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CYCS—hematologic cancer	7.13e-06	0.000114	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—FN1—hematologic cancer	7.1e-06	0.000114	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.09e-06	0.000113	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—HSP90AA1—hematologic cancer	7.08e-06	0.000113	CbGpPWpGaD
Diflunisal—ALB—Metabolism—UGT1A1—hematologic cancer	7.06e-06	0.000113	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CBL—hematologic cancer	7.04e-06	0.000113	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—SDC1—hematologic cancer	7.03e-06	0.000113	CbGpPWpGaD
Diflunisal—TTR—Disease—KRAS—hematologic cancer	7.03e-06	0.000113	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	6.98e-06	0.000112	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CDKN1B—hematologic cancer	6.97e-06	0.000111	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CRABP1—hematologic cancer	6.87e-06	0.00011	CbGpPWpGaD
Diflunisal—ALB—Metabolism—SLC22A1—hematologic cancer	6.87e-06	0.00011	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CASP3—hematologic cancer	6.83e-06	0.000109	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IL2—hematologic cancer	6.82e-06	0.000109	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PIK3CG—hematologic cancer	6.79e-06	0.000109	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.72e-06	0.000108	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HSP90AA1—hematologic cancer	6.71e-06	0.000107	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ALOX5—hematologic cancer	6.69e-06	0.000107	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PTPN11—hematologic cancer	6.67e-06	0.000107	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CCND1—hematologic cancer	6.65e-06	0.000106	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.63e-06	0.000106	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—JUN—hematologic cancer	6.63e-06	0.000106	CbGpPWpGaD
Diflunisal—ALB—Metabolism—NUP98—hematologic cancer	6.48e-06	0.000104	CbGpPWpGaD
Diflunisal—PTGS2—Disease—STAT1—hematologic cancer	6.47e-06	0.000104	CbGpPWpGaD
Diflunisal—TTR—Disease—PIK3CA—hematologic cancer	6.46e-06	0.000103	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CDKN1A—hematologic cancer	6.43e-06	0.000103	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PTEN—hematologic cancer	6.41e-06	0.000103	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.37e-06	0.000102	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.34e-06	0.000102	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—CREBBP—hematologic cancer	6.3e-06	0.000101	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ADCY7—hematologic cancer	6.29e-06	0.000101	CbGpPWpGaD
Diflunisal—ALB—Metabolism—NCOA3—hematologic cancer	6.29e-06	0.000101	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GSTP1—hematologic cancer	6.28e-06	0.000101	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MAPK8—hematologic cancer	6.27e-06	0.0001	CbGpPWpGaD
Diflunisal—ALB—Metabolism—NUP214—hematologic cancer	6.25e-06	0.0001	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—AKT1—hematologic cancer	6.2e-06	9.93e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.18e-06	9.89e-05	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	6.15e-06	9.85e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—MTR—hematologic cancer	6.12e-06	9.79e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ABCG2—hematologic cancer	6.12e-06	9.79e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—EP300—hematologic cancer	6.12e-06	9.79e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.08e-06	9.73e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—GRB2—hematologic cancer	6.06e-06	9.69e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PDGFA—hematologic cancer	6.04e-06	9.67e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ENO2—hematologic cancer	6e-06	9.6e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—NQO1—hematologic cancer	5.98e-06	9.57e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CD44—hematologic cancer	5.98e-06	9.57e-05	CbGpPWpGaD
Diflunisal—TTR—Disease—HRAS—hematologic cancer	5.98e-06	9.56e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PIK3CD—hematologic cancer	5.97e-06	9.55e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—KITLG—hematologic cancer	5.96e-06	9.53e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—SRC—hematologic cancer	5.95e-06	9.52e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ABCB1—hematologic cancer	5.95e-06	9.52e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.86e-06	9.37e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTT1—hematologic cancer	5.82e-06	9.32e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—STAT5A—hematologic cancer	5.82e-06	9.31e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—VEGFA—hematologic cancer	5.79e-06	9.27e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GSTM1—hematologic cancer	5.77e-06	9.24e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—NCOR1—hematologic cancer	5.77e-06	9.24e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CDKN2B—hematologic cancer	5.77e-06	9.23e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—STAT3—hematologic cancer	5.74e-06	9.18e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.73e-06	9.17e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—NRAS—hematologic cancer	5.72e-06	9.16e-05	CbGpPWpGaD
Diflunisal—TTR—Disease—IL6—hematologic cancer	5.72e-06	9.15e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—SDC1—hematologic cancer	5.69e-06	9.11e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYCS—hematologic cancer	5.66e-06	9.05e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PIK3R1—hematologic cancer	5.64e-06	9.02e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—HSP90AA1—hematologic cancer	5.62e-06	9e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CD86—hematologic cancer	5.58e-06	8.93e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HES1—hematologic cancer	5.51e-06	8.81e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MAPK3—hematologic cancer	5.48e-06	8.77e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—JAK2—hematologic cancer	5.48e-06	8.77e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—NCOR1—hematologic cancer	5.47e-06	8.76e-05	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.45e-06	8.72e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.44e-06	8.7e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—FGF1—hematologic cancer	5.41e-06	8.66e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—FOXO1—hematologic cancer	5.33e-06	8.53e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MYC—hematologic cancer	5.33e-06	8.53e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PDGFRB—hematologic cancer	5.32e-06	8.52e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TGFB1—hematologic cancer	5.32e-06	8.51e-05	CbGpPWpGaD
Diflunisal—TTR—Disease—AKT1—hematologic cancer	5.28e-06	8.45e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PDGFRA—hematologic cancer	5.24e-06	8.39e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—JAK1—hematologic cancer	5.22e-06	8.36e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PRKCG—hematologic cancer	5.22e-06	8.36e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PIK3CB—hematologic cancer	5.2e-06	8.33e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.13e-06	8.21e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—MTHFR—hematologic cancer	5.1e-06	8.17e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.06e-06	8.1e-05	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	5.03e-06	8.04e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GSTP1—hematologic cancer	4.99e-06	7.98e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—KRAS—hematologic cancer	4.93e-06	7.88e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—NQO1—hematologic cancer	4.84e-06	7.74e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CD44—hematologic cancer	4.84e-06	7.74e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MTHFR—hematologic cancer	4.84e-06	7.74e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.83e-06	7.72e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HLA-A—hematologic cancer	4.82e-06	7.72e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TERT—hematologic cancer	4.82e-06	7.72e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IL2—hematologic cancer	4.78e-06	7.65e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.74e-06	7.58e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ABCB1—hematologic cancer	4.72e-06	7.55e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PDGFB—hematologic cancer	4.71e-06	7.53e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TSC2—hematologic cancer	4.6e-06	7.36e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GSTM1—hematologic cancer	4.58e-06	7.33e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—NCOR1—hematologic cancer	4.58e-06	7.33e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYCS—hematologic cancer	4.58e-06	7.33e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—HSP90AA1—hematologic cancer	4.55e-06	7.28e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PIK3CA—hematologic cancer	4.52e-06	7.24e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.5e-06	7.2e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—FGFR3—hematologic cancer	4.43e-06	7.08e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TP53—hematologic cancer	4.38e-06	7e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—EP300—hematologic cancer	4.29e-06	6.86e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PIK3CG—hematologic cancer	4.29e-06	6.86e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—BAD—hematologic cancer	4.2e-06	6.71e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—HRAS—hematologic cancer	4.19e-06	6.7e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—SRC—hematologic cancer	4.17e-06	6.67e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—NOTCH1—hematologic cancer	4.16e-06	6.65e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.09e-06	6.55e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CD80—hematologic cancer	4.07e-06	6.51e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—KIT—hematologic cancer	4.06e-06	6.5e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—VEGFA—hematologic cancer	4.06e-06	6.5e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—MTHFR—hematologic cancer	4.05e-06	6.48e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTP1—hematologic cancer	4.04e-06	6.46e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—NRAS—hematologic cancer	4.01e-06	6.42e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IL6—hematologic cancer	4.01e-06	6.41e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PTPN11—hematologic cancer	3.99e-06	6.39e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CREBBP—hematologic cancer	3.98e-06	6.36e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.9e-06	6.25e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CREB1—hematologic cancer	3.87e-06	6.19e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—MAPK3—hematologic cancer	3.84e-06	6.15e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—BRAF—hematologic cancer	3.82e-06	6.11e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ABCB1—hematologic cancer	3.82e-06	6.11e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—IL6R—hematologic cancer	3.77e-06	6.04e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PIK3CD—hematologic cancer	3.77e-06	6.03e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CREBBP—hematologic cancer	3.77e-06	6.03e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TGFB1—hematologic cancer	3.73e-06	5.97e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ALB—hematologic cancer	3.72e-06	5.95e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTM1—hematologic cancer	3.71e-06	5.93e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—NCOR1—hematologic cancer	3.71e-06	5.93e-05	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—AKT1—hematologic cancer	3.7e-06	5.91e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MAP2K1—hematologic cancer	3.6e-06	5.75e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PIK3CD—hematologic cancer	3.57e-06	5.72e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.57e-06	5.71e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PIK3R1—hematologic cancer	3.56e-06	5.69e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—KRAS—hematologic cancer	3.45e-06	5.53e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—FGF2—hematologic cancer	3.42e-06	5.47e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PIK3CG—hematologic cancer	3.4e-06	5.45e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PIK3R1—hematologic cancer	3.37e-06	5.4e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PIK3CB—hematologic cancer	3.29e-06	5.26e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—JAK2—hematologic cancer	3.28e-06	5.25e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—MTHFR—hematologic cancer	3.28e-06	5.24e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MDM2—hematologic cancer	3.2e-06	5.12e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PIK3CA—hematologic cancer	3.17e-06	5.08e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CREBBP—hematologic cancer	3.16e-06	5.05e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MTOR—hematologic cancer	3.11e-06	4.98e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PIK3CB—hematologic cancer	3.11e-06	4.98e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CD4—hematologic cancer	3.11e-06	4.97e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TP53—hematologic cancer	3.07e-06	4.91e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PIK3CD—hematologic cancer	2.99e-06	4.79e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ALB—hematologic cancer	2.95e-06	4.73e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—HRAS—hematologic cancer	2.94e-06	4.7e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CDKN1B—hematologic cancer	2.92e-06	4.68e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.89e-06	4.62e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PTEN—hematologic cancer	2.84e-06	4.54e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PIK3R1—hematologic cancer	2.83e-06	4.52e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PIK3CG—hematologic cancer	2.75e-06	4.41e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—EP300—hematologic cancer	2.71e-06	4.33e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CDKN1A—hematologic cancer	2.7e-06	4.32e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PTEN—hematologic cancer	2.69e-06	4.31e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PIK3CB—hematologic cancer	2.61e-06	4.17e-05	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—AKT1—hematologic cancer	2.59e-06	4.15e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—EP300—hematologic cancer	2.57e-06	4.11e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CREBBP—hematologic cancer	2.55e-06	4.09e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SRC—hematologic cancer	2.5e-06	3.99e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PIK3CD—hematologic cancer	2.42e-06	3.87e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—STAT3—hematologic cancer	2.41e-06	3.85e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—NRAS—hematologic cancer	2.4e-06	3.84e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MAPK3—hematologic cancer	2.3e-06	3.68e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PIK3R1—hematologic cancer	2.29e-06	3.66e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PTEN—hematologic cancer	2.25e-06	3.61e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MYC—hematologic cancer	2.24e-06	3.58e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TGFB1—hematologic cancer	2.23e-06	3.57e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—EP300—hematologic cancer	2.15e-06	3.44e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PIK3CB—hematologic cancer	2.11e-06	3.38e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—KRAS—hematologic cancer	2.07e-06	3.31e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PIK3CA—hematologic cancer	2e-06	3.2e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PIK3CA—hematologic cancer	1.9e-06	3.04e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PTEN—hematologic cancer	1.82e-06	2.92e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HRAS—hematologic cancer	1.76e-06	2.81e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—EP300—hematologic cancer	1.74e-06	2.78e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—IL6—hematologic cancer	1.68e-06	2.69e-05	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—AKT1—hematologic cancer	1.64e-06	2.62e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PIK3CA—hematologic cancer	1.59e-06	2.54e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—AKT1—hematologic cancer	1.55e-06	2.48e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—AKT1—hematologic cancer	1.3e-06	2.08e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PIK3CA—hematologic cancer	1.29e-06	2.06e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—AKT1—hematologic cancer	1.05e-06	1.68e-05	CbGpPWpGaD
